相似文献
1
Severe immune thrombocytopenia in a critically ill COVID-19 patient.
Int J Infect Dis. 2020 Oct;99:269-271. doi: 10.1016/j.ijid.2020.08.002. Epub 2020 Aug 6.
2
COVID-19-associated immune thrombocytopenia.
Br J Haematol. 2020 Jul;190(2):e61-e64. doi: 10.1111/bjh.16850. Epub 2020 Jun 8.
3
Severe immune thrombocytopenic purpura in critical COVID-19.
Int J Hematol. 2020 Nov;112(5):746-750. doi: 10.1007/s12185-020-02931-9. Epub 2020 Jul 1.
4
COVID-19 patient with immune thrombocytopenic purpura.
Int J Lab Hematol. 2020 Dec;42(6):e260-e262. doi: 10.1111/ijlh.13303. Epub 2020 Aug 12.
5
COVID-19 as a cause of immune thrombocytopenia.
Med Mal Infect. 2020 Aug;50(5):459-460. doi: 10.1016/j.medmal.2020.05.003. Epub 2020 May 20.
6
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.
Thromb Res. 2020 Nov;195:136-138. doi: 10.1016/j.thromres.2020.07.005. Epub 2020 Jul 5.
7
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Ann Hematol. 2020 Aug;99(8):1951-1952. doi: 10.1007/s00277-020-04130-2. Epub 2020 Jun 11.
8
Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: A case report.
Br J Haematol. 2020 Aug;190(3):e146-e148. doi: 10.1111/bjh.16928. Epub 2020 Jun 30.
9
Immune Thrombocytopenic Purpura in a Patient with Covid-19.
N Engl J Med. 2020 Apr 30;382(18):e43. doi: 10.1056/NEJMc2010472. Epub 2020 Apr 15.
10
Immune thrombocytopenia in a patient with COVID-19.
Int J Hematol. 2020 Dec;112(6):883-888. doi: 10.1007/s12185-020-02943-5. Epub 2020 Jul 16.
引用本文的文献
1
Thrombocytopenia in Sepsis.
Life (Basel). 2025 Feb 11;15(2):274. doi: 10.3390/life15020274.
2
SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports.
Ann Hematol. 2024 Oct;103(10):3921-3939. doi: 10.1007/s00277-024-05765-1. Epub 2024 Apr 23.
3
Current knowledge of thrombocytopenia in sepsis and COVID-19.
Front Immunol. 2023 Sep 28;14:1213510. doi: 10.3389/fimmu.2023.1213510. eCollection 2023.
4
Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review.
Heliyon. 2022 Nov;8(11):e11328. doi: 10.1016/j.heliyon.2022.e11328. Epub 2022 Nov 1.
5
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.
Nat Commun. 2022 May 16;13(1):2687. doi: 10.1038/s41467-022-30357-w.
6
SARS-CoV-2 triggering autoimmune diseases.
Cytokine. 2022 Jun;154:155873. doi: 10.1016/j.cyto.2022.155873. Epub 2022 Apr 5.
7
Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
Respir Med Case Rep. 2021;34:101563. doi: 10.1016/j.rmcr.2021.101563. Epub 2021 Dec 2.
8
Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
Int J Infect Dis. 2022 Feb;115:8-16. doi: 10.1016/j.ijid.2021.11.028. Epub 2021 Nov 25.
9
Immune thrombocytopenia, severe hematological consequence in a patient with COVID-19: A case report.
Exp Ther Med. 2021 Sep;22(3):1043. doi: 10.3892/etm.2021.10475. Epub 2021 Jul 21.
10
Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity.
Int Immunopharmacol. 2021 Oct;99:107995. doi: 10.1016/j.intimp.2021.107995. Epub 2021 Jul 21.
本文引用的文献
1
Severe immune thrombocytopenic purpura in critical COVID-19.
Int J Hematol. 2020 Nov;112(5):746-750. doi: 10.1007/s12185-020-02931-9. Epub 2020 Jul 1.
2
Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review.
Ann Transl Med. 2020 May;8(10):625. doi: 10.21037/atm-20-3305.
3
Autoimmune and inflammatory diseases following COVID-19.
Nat Rev Rheumatol. 2020 Aug;16(8):413-414. doi: 10.1038/s41584-020-0448-7.
4
COVID-19-associated immune thrombocytopenia.
Br J Haematol. 2020 Jul;190(2):e61-e64. doi: 10.1111/bjh.16850. Epub 2020 Jun 8.
5
Coagulation abnormalities and thrombosis in patients with COVID-19.
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
6
Autoimmune haemolytic anaemia associated with COVID-19 infection.
Br J Haematol. 2020 Jul;190(1):29-31. doi: 10.1111/bjh.16794. Epub 2020 May 27.
7
Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity.
J Transl Autoimmun. 2020 Apr 9;3:100051. doi: 10.1016/j.jtauto.2020.100051. eCollection 2020.
8
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.044. Epub 2020 Apr 10.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
10
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
Zotero 插件